Literature DB >> 18287845

Tc-99m pertechnetate/sestamibi subtraction scan in a case of parathyroid carcinoma.

Tarun Singhal1, Martin Jacobs, Joseph C Mantil.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18287845     DOI： 10.1097/RLU.0b013e318162dd4d

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN： 0363-9762            Impact factor:   7.794


× No keyword cloud information.
  3 in total

1.  Differential findings of tc-99m sestamibi dual-phase parathyroid scintigraphy between benign and malignant parathyroid lesions in patients with primary hyperparathyroidism.

Authors:  Miju Cheon; Joon Young Choi; Jae-Hoon Chung; Ji Young Lee; Sook Kyung Cho; Jang Yoo; Soo Bin Park; Kyung-Han Lee; Byung-Tae Kim
Journal:  Nucl Med Mol Imaging       Date:  2011-08-19

Review 2.  Parathyroid carcinoma: current understanding and new insights into gene expression and intraoperative parathyroid hormone kinetics.

Authors:  Mohamed Abdelgadir Adam; Brian R Untch; John A Olson
Journal:  Oncologist       Date:  2010-01-05

Review 3.  Is there a consensus between clinical practice guidelines for conventional and molecular nuclear medicine studies in parathyroid pathology?

Authors:  Marylin Acuña Hernandez; Liset Sanchez Orduz; Uvi Cancino Ramos; Paola Vallejo Armenta; Leonardo Cadavid Blanco
Journal:  Ann Nucl Med       Date:  2021-07-24       Impact factor: 2.668
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.